Kendra Adams
Director of Finance/CFO at C4 THERAPEUTICS, INC.
Net worth: 670 259 $ as of 2024-03-30
Profile
Kendra R.
Adams is currently the Chief Financial Officer & Treasurer at C4 Therapeutics, Inc. She previously worked as the Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and as the VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Ms. Adams completed her undergraduate degree at Hamilton College (New York).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.12% | 2024-03-06 | 82,039 ( 0.12% ) | 670 259 $ | 2024-03-30 |
Kendra Adams active positions
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director of Finance/CFO | 2023-09-17 |
Former positions of Kendra Adams
| Companies | Position | End |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of Kendra Adams
| Hamilton College (New York) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kendra Adams
